Natera Selected for UnitedHealthcare’s Preferred Laboratory Network

AUSTIN, Texas, July 14, 2022 /PRNewswire/ — Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA (cfDNA) testing, today announced it has been selected to participate in UnitedHealthcare’s Preferred Laboratory Network (PLN). Natera’s addition to the network was effective July 1,…

About the Author

has written 41821 stories on this site.

Copyright © 2010 Business and Corporate News.